Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

98 results about "Contagious disease" patented technology

A disease that can spread from one person to another through direct or indirect contact.

Live attenuated antigenically marked classical swine fever virus

Classical swine fever virus is a world-wide distributed highly-contagious disease affecting swine. The two main strategies for diseases control are prophylactic vaccination and non-vaccination stamping out policies. Marker vaccines are a promising strategy. Here we report the rational development of a doubly antigenic marker CSFV experimental live attenuated candidate strain vaccine (Flag/T4 virus). Flag/T virus (Flag/T4v) is based in the combination of two Brescia derived recombinant attenuated viruses: RB-C22 and T4. RB-C22v contains a 19mer insertion in the structural glycoprotein E1, while T4v posses mutated CSFV amino acid residues 830 to 834 in the structural glycoprotein E2, deleting the highly conserved epitope recognized by monoclonal antibody (mAb) WH303. Flag/T4 virus contains a positive foreign antigenic marker, due to the insertion of the highly antigenic epitope Flag in the 19mer insertion of E1, as well as a negative antigenic marker, the lack of reactivity with mAb WH303. Immunized with Flag/T4v induced a complete protection against the challenge with virulent strain Brescia both at 3 and 28 days post infection when nasally administered and since the second day post infection when intramuscularly administered. These results constitute an example of rational design of a CSFV antigenically marked LAV.
Owner:AGRI UNITED STATES OF AMERICA AS RESPRESENTED BY THE SEC OF THE +1

Indazolinone compositions useful as kinase inhibitors

The present invention provides compounds of formula I:These compounds, and pharmaceutically acceptable compositions thereof, are useful generally as kinase inhibitors, particularly as inhibitors of PRAK, GSK3, ERK2, CDK2, MK2, SRC, SYK, and Aurora-2. Accordingly, compounds and compositions of the invention are useful for treating or lessening the severity of a variety of disorders, including, but not limited to, heart disease, diabetes, Alzheimer's disease, immunodeficiency disorders, inflammatory diseases, allergic diseases, autoimmune diseases, destructive bone disorders such as osteoporosis, proliferative disorders, infectious diseases and viral diseases.
Owner:VERTEX PHARMA INC

Portable specific vomit device for infectious disease

The invention relates to a portable specific vomit device for an infectious disease and belongs to the technical field of medical utensils. The portable specific vomit device for the infectious disease comprises a box body. An operation panel is arranged on the front side of the box body; a flushing water box is arranged on the left side of the box body; the lower side of the flush water box is provided with a power supply box; an auxiliary back belt is mounted on the rear side of the box body; a foldable combination hose is mounted on the upper side of the box body; a moth mask accommodatingbox is formed in the right side of the foldable combination hose; a hose fixing clip is cooperated to the upper surface of the foldable combination hose; a sealing mouth mask is mounted on the upper side of the foldable combination hose; a disinfection and sterilizing box is disposed in the box body; a flushing protection plate is placed in the sealing mouth mask; a diversion flushing groove is formed in the right side of the flushing protection plate; and a flushing nozzle is formed in the upper side of the diversion flushing groove. The portable specific vomit device for the infectious disease is simply structured and convenient to use; an infectious disease patient can carry the device, so vomit can be flushed and sealed, and odor of the vomit and saliva splash can be prevented; and patient vomit can be sterilized and disinfected, so bacteria can be fully killed and cross infection can be avoided.
Owner:孙燕妮

Live attenuated antigenically marked classical swine fever virus

Classical swine fever virus is a world-wide distributed highly-contagious disease affecting swine. The two main strategies for diseases control are prophylactic vaccination and non-vaccination stamping out policies. Marker vaccines are a promising strategy. Here we report the rational development of a doubly antigenic marker CSFV experimental live attenuated candidate strain vaccine (Flag / T4 virus). Flag / T virus (Flag / T4v) is based in the combination of two Brescia derived recombinant attenuated viruses: RB-C22 and T4. RB-C22v contains a 19mer insertion in the structural glycoprotein E1, while T4v posses mutated CSFV amino acid residues 830 to 834 in the structural glycoprotein E2, deleting the highly conserved epitope recognized by monoclonal antibody (mAb) WH303. Flag / T4 virus contains a positive foreign antigenic marker, due to the insertion of the highly antigenic epitope Flag in the 19mer insertion of E1, as well as a negative antigenic marker, the lack of reactivity with mAb WH303. Immunized with Flag / T4v induced a complete protection against the challenge with virulent strain Brescia both at 3 and 28 days post infection when nasally administered and since the second day post infection when intramuscularly administered. These results constitute an example of rational design of a CSFV antigenically marked LAV.
Owner:AGRI UNITED STATES OF AMERICA AS RESPRESENTED BY THE SEC OF THE +1
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products